Trauma induced tissue survival in vitro with a muscle-biomaterial based osteogenic organoid system: a proof of concept study by He, Tao et al.
RESEARCH ARTICLE Open Access
Trauma induced tissue survival in vitro with
a muscle-biomaterial based osteogenic
organoid system: a proof of concept study
Tao He1,2*, Jörg Hausdorf1, Yan Chevalier1 and Roland M. Klar1*
Abstract
Background: The translation from animal research into the clinical environment remains problematic, as animal
systems do not adequately replicate the human in vivo environment. Bioreactors have emerged as a good
alternative that can reproduce part of the human in vivo processes at an in vitro level. However, in vitro bone
formation platforms primarily utilize stem cells only, with tissue based in vitro systems remaining poorly
investigated. As such, the present pilot study explored the tissue behavior and cell survival capability within a new
in vitro skeletal muscle tissue-based biomaterial organoid bioreactor system to maximize future bone tissue
engineering prospects.
Results: Three dimensional printed β-tricalcium phosphate/hydroxyapatite devices were either wrapped in a sheet
of rat muscle tissue or first implanted in a heterotopic muscle pouch that was then excised and cultured in vitro for
up to 30 days. Devices wrapped in muscle tissue showed cell death by day 15. Contrarily, devices in muscle
pouches showed angiogenic and limited osteogenic gene expression tendencies with consistent TGF-ß1, COL4A1,
VEGF-A, RUNX-2, and BMP-2 up-regulation, respectively. Histologically, muscle tissue degradation and fibrin release
was seen being absorbed by devices acting possibly as a support for new tissue formation in the bioceramic
scaffold that supports progenitor stem cell osteogenic differentiation.
Conclusions: These results therefore demonstrate that the skeletal muscle pouch-based biomaterial culturing
system can support tissue survival over a prolonged culture period and represents a novel organoid tissue model
that with further adjustments could generate bone tissue for direct clinical transplantations.
Keywords: Heterotopic implant model, In vitro, Tissue survival, Angiogenesis, Vasculogenesis, 3D printed β-TCP/HA,
Pilot study, Organoid
Background
The effective translation from in vitro to in vivo and
in vivo to clinical practice remains a major challenge for
tissue regenerative sciences [1–3]. Whilst experimental
in vitro and in vivo investigations continue to contribute
greatly to deciphering specific criteria in biological sci-
ences, the translation from a functional model to the
clinical setting takes an exuberant amount of time and
consumes vast resources [4]. This is one of the reasons
why bone tissue induction models are not yet used and
the autogenous bone graft [5–9] remains the golden
standard for bone regeneration clinically.
There is a clear need to develop more reliable ex vivo
models where bioreactor platforms, simulating certain
tissue types, have shown great capabilities at replicating
certain in vivo environments [10, 11]. However, bioreac-
tors remain problematic for use in forming a complex
structure like bone, as there are various biochemical, cel-
lular and mechanical requirements that need to be met
to form this tissue type either ectopically or orthotopi-
cally [12–19], where vascularization and/or angiogenesis
are essential components that help the tissue survive
and grow [20, 21].
Most bioreactor platforms utilize stem cells on a spe-
cific biomaterial to produce a specific single cell derived
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tissue type [22–24], which is inadequate for bone tissue
morphogenesis as various steps are required that together
culminate in the formation of this tissue [25]. Additionally,
cells cultured in vitro not only lose their homeostatic state
through the loss of essential amino acids, that growth
medium can hardly supply in a controlled and released
state as in vivo tissue breakdown would [26], but also need
to develop a viable extracellular matrix (ECM) environ-
ment first before they can thrive and grow [27, 28]. Hence,
in vivo tissue based bone inductive studies remain to date
the best models to study the effect of biomaterial behavior
in vivo. As such, a tissue-based bioreactor platform [23,
29, 30] could be superior to that of a stem cell-based sys-
tem as tissues possesses various biochemical building
blocks and adult stem cell niches together with pre-
established cell growth promoting environments that
theoretically could provide a superior culturing milieu.
However, the use of bone directly as a biomaterial growth
environment in vitro is highly problematic, as culture
medium cannot adequately diffuse across a hard tissue
barrier [30]. Therefore, the present pilot study investigated
the feasibility of two in vitro skeletal muscle-based
biomaterial-culturing systems as this tissue, being consid-
ered among the promising candidate grafts for bone tissue
engineering, allows for better nutrient flow [31–33]. The
primary objective was to see if the models would support
tissue survivability and growth into a custom three-
dimensional (3D) printed bone inductive biomaterial [34,
35], whereas the secondary objective was to determine if
any vasculo−/angiogenic morphogenesis, by monitoring
transcriptional and translational markers, would take place
as this is a crucial component required for nascent bone
tissue formation [20, 21].
Results
Tissue pouch model supported superior tissue survival
and transformation than tissue wrapping model in vitro
Many investigators have designed 3D osteogenic biore-
actors utilizing different sources of cells and types of
scaffolds [23, 36, 37]. However, the osteogenic trans-
formation of fibrous tissue in vitro is conceived impos-
sible owing to the lack of a blood supply [20]. This study
attempted for the first time to establish a tissue-scaffold
complex in vitro that would support tissue survivability
ex vivo and cast light on inducing de novo bone forma-
tion over a long culturing period, and is meant to repli-
cate the normal in vivo experimental environmental
conditions of most known extra skeletal bone inductive
models [12, 13, 16, 35].
The abdominal skeletal muscle tissue of adult male Fi-
scher 344/DuCrl rats was utilized, where macro−/micro-
porous β-TCP/HA were either wrapped in the tissue
harvested or where β-TCP/HA devices were first im-
planted in non-harvested muscle pouch within
heterotopic sites, the standard experimental form to test
new bone induction in vivo, and then excised before be-
ing cultured in vitro (Fig. 1). Implantation duration was
limited to maximum of 30min to prevent advanced tis-
sue decay. In order to test the cell survival capacity of
these two models, we extended the culturing time up to
30 days, where no evidence, to our knowledge, has yet
reported on culturing muscle tissue ex vivo for more
than 30 days. The tissue thickness was ~ 1500 μm in the
wrapping model and ~ 500 μm in the pouch model. In
the tissue wrapping model, no gene expression data
could be generated for the 30-day in vitro β-TCP/HA
wrapped in skeletal muscle tissue from rats (Fig. 2i, Fig.
5c), as the tissue became necrotic, gradually losing the
original tissue structure with fading of nuclei preventing
successful extraction of mRNA to be available for quan-
titative real-time polymerase chain reactions (qRT-PCR)
analysis (Fig. 2a-c, Fig. 3a-d). On the other hand, single
cells on β-TCP/HA devices pouched in the skeletal
muscle survived the 30-day in vitro culturing process
(Fig. 2d-f, i, Fig. 3e-h), with no bacterial contamination
in the culturing system (Fig. 4). Furthermore, histo-
logical analysis showed a consistent tissue survival
around the scaffold in the pouch model up to 30 days,
with ongoing tissue necrosis in the wrapping model over
time.
With the goal of defining the difference of gene expression
pattern between these two models and evaluate which
method provides better tissue survival with possible osteo-
genic tendencies we then compared the qRT-PCR data be-
tween them. The tissue wrapping model, only at day 15
in vitro showed an up-regulation of tissue survival and
angiogenesis markers including vascular epithelial growth
factor α (VEGF-A) and collagen type 4 subunit 1 (COL4A1)
and transforming growth factor β1 (TGF-β1) (Fig. 2h),
whereas β-TCP/HA bioceramics pouched in abdominal skel-
etal muscle tissue of rats showed a considerable increase in
angiogenesis and endothelial tissue formation genes expres-
sion at all time points (Fig. 2 g-i). For osteogenic differenti-
ation markers, only bone morphogenetic protein 2 (BMP-2)
up-regulation was noticed at day 5 in the wrapping model
(Fig. 5a), while both runt-related transcription factor 2
(RUNX-2) and BMP-2 were steadily up-regulated over time
in the pouch model and expressed at higher levels than in
the wrapping model at day 30 (P < 0.01) (Fig. 5a-c). These re-
sults suggest better tissue survival in vitro in a tissue pouch
model.
Maintenance of vascular structure and stimulation of
osteogenesis in tissue pouch models
Upon demonstrating better tissue survivability and
growth in the tissue pouch model through histology and
gene expression patterns representative of cytoprolifera-
tion and differentiation supporting new tissue formation,
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the chronological change of VEGF-A gene expression and
protein production pattern up to 30 days of the culturing
process and histological results at day 30 were assessed in
the heterotopic pouch model (Fig. 6). This aimed to deter-
mine if a regulatory gene pattern could be identified and
prove that this model indeed supports vascular structure
maintenance and potential angiogenesis.
In β-TCP/HA bioceramic devices muscle pouch
model, the best up-regulated genes were COL4A1,
VEGF-A and TGF-β1 at day 15 and day 30, whilst at day
5 it was COL4A1, BMP-2 and VEGF-A (Fig. 2, Fig. 5). In
short, COL4A1 and VEGF-A were highly up-regulated at
all time points, whilst a marked high expression of
BMP-2 occurred at day 30 compared with muscle tissue
alone (P < 0.05) (Fig. 7i). Our findings, in the gene ex-
pression aspect, suggest that the bioceramic devices im-
planted in the muscle pouch support vessel survival and
potential angiogenesis when cultured under normal
in vitro growth conditions with limited osteogenic ten-
dencies present, especially 30 days after treatment.
Tissue pouch models initiate osteogenic morphogenesis
ex vivo
Histological sections of β-TCP/HA bioceramic devices
wrapped in rat abdominal skeletal muscle tissue clearly
showed a thin layer of fibrous-like tissue lining the inter-
face between muscle tissue and scaffold at day 5 (Fig.
2a). In contrast, fibrils and cells were released from the
injured muscle fibers and attached to the interface of the
scaffold (Fig. 2d). Successively, a noticeable increase of
the volume of necrotic muscle fibers was observed at
day 15 in the bioceramic muscle tissue wrapped model
(Fig. 2b), with limited numbers of condensed nuclei con-
taining fibers sparsely distributed within ECM at the
Fig. 1 In vitro wrapping and heterotopic implanted bioceramic pouch model methodology (a-h). The three-dimensional printed macro-porous
β-tricalcium phosphate/hydroxyapatite (β-TCP/HA) bioceramic devices (a), for the wrapping or pouch models, were placed in growth medium
(DMEM), prior to either wrapping them in rat skeletal rectus abdominis muscle tissue (b-d), or implanting them first in heterotopic extra-skeletal
rectus abdominis muscle sites (e-h) of euthanized rats. The implant sites with devices were then harvested, devices embedded in the muscle
tissue excised, and subsequently placed in growth medium to be cultured for 5, 15 and 30 days in vitro. (All images within Fig. 1 originate from
our own laboratory. Images were not taken from other sources)
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periphery of the devices. In contrast, muscle tissue of
the bioceramic devices in the heterotopic pouch model,
at day 15, appeared to actively “invade” and undergo a
transformation, into connective tissue (Fig. 2e) that was
clearly visible at the tissue to scaffold microporous inter-
face and could partially be observed lining the macro-
porous hole-like structures of the scaffold (Fig. 2e higher
magnification view). By day 30, in contrast to tissue
pouched bioceramic devices, as represented in Fig. 2f,
tissue survival was compromised in the wrapping model,
where the muscle tissue on the periphery of the biocera-
mic device was observed to undergo a type of fragmen-
tation, discontinuing fibrous tissue growth at the muscle
to device interface (Fig. 2c), without any presence of liv-
ing cells within the scaffold (Fig. 2c higher magnification
view). Contrarily, for the 30 days heterotopic pouch
model group, the muscle tissue was seen breaking down
(Fig. 7c and g), yet obviously supporting connective tis-
sue that was observed invading, although mainly at the
periphery, into the macroporous superstructure of the β-
TCP/HA devices (Fig. 7d and h), with fibrils also appear-
ing to interact with the particles of the porotic biocera-
mic scaffold. No cells or tissues pertaining to bone
formation could be visualized. Subsequently, during
muscle tissue degeneration, cells within and between the
muscle tissue fibers were released and appeared to be
migrating into the scaffold together with the extra-
cellular matrix (Fig. 7a, c and d). Certain transitional
zones showed some signs of a collagen-osteoid-like
matrix forming near the connective tissue to porous
superstructure interphase of the device (Fig. 7e and h).
These results indicated that cell migration could be initi-
ated as early as day 5, being supported up to 30 days by
connective tissue in the tissue pouch model, with limited
Fig. 2 Comparison of tissue survivability between the two in vitro models in growth medium at day 5, 15 and 30 (a-i). Cells are confined at the
interface between muscle and scaffold at day 5 in the wrapping model (a), with a shock silence of tissue-survival related genes (g). Muscle tissue
undergo necrosis over time (b) with dying of cells (c, i). In pouch models, initial cell releasing occurs at day 5 (d), leading to successive cell
migration and connective tissue formation (e). Vessel structures (f, higher power view) are still present by day 30 in vitro culturing with consistent
tissue survival and growth gene expression pattern. Gene expression assays show better tissue survival in the pouch model, especially at day 30
(g-i). Error bars are Mean ± SEM. Ns, non-statistically significant; *, P < 0.05; ***, P < 0.001. H&E staining. M = Skeletal muscle, S = scaffold, CT =
connective tissue. Bar: Lower power, 200 μm; higher power, 20 μm
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formation of collagen-osteoid-like matrices at the per-
ipheries of the porous device.
Discussion
Developing a new technology that can fully replicate,
synthetically, an in vivo environment in vitro, how-
ever challenging, is attractive as it would allow for
more efficient testing on par with the physiological
reality of the clinical setting. It is expected that such
medically supportive platforms would deliver faster
and superior results with reduced costs whilst allow-
ing for more accurate prediction and therapeutic
models to be developed for a clinical setting [38].
Whilst one solution to this problem has been the
emergence of bioreactor platforms [10, 11, 39, 40]
that have a limited capacity at replicating some
in vivo processes, developing a synthetic system that
can fully replicate the supra-organ of bone(s),
let alone induce bone formation in vitro, with its
plethora of varying proteins arranged geometrically
within the 3D superstructure and assortment of cellu-
lar entities [40, 41] remains perhaps the most challen-
ging prospect for tissue engineering regenerative
sciences with only the neurological complexities of
Fig. 3 Morphology and tissue response to devices in wrapping models and pouch models at day 5 and day 15 (a-h). A considerable amount of
fibrils were seen forming into the device (a, f; blue arrows) with some collagen-osteoid formation (green arrow) noticeable at days 5, while the
self-adaptation of tissue at the periphery of device was observed in both models (b, e; pink arrows). In contrast, to tissue implanted
heterotopically (g, h; blue arrows) the survivability of tissue was compromised in the tissue bag model at days 15, where the muscle tissue on
the periphery of the bioceramic device was observed to undergo a type of fragmentation, discontinuing fibrous tissue formation at the interface
of the muscle and device (c, d; pink arrows). Movat pentachrome staining was utilized to assess for collagen associated with chondrogenesis
and osteogenesis, elastic fibers, muscle and connective tissue. Bars: A, B, D, E, F and H = 100 μm; C and G = 200 μm
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the brain surpassing this endeavor. In the hereby pre-
sented pilot study, the first nascent steps towards devel-
oping such a bone inductive/formative environmental
reality in vitro was attempted. Systematic studies can be
further developed and improved to produce in vitro bone
formation of any skeletal bone in view of clinical
applications.
The bone induction principle dictates that soluble mo-
lecular signal(s) combined with an insoluble substratum
are critical for the initiation and formation of de novo
bone tissue formation in vivo [13, 42]. The prerequisite,
in order to facilitate proper bone formation, is an ad-
equate vascular supply, formed either by vasculogenesis
and/or angiogenesis, with vessel structures invading the
macro- and microporous superstructure of a device and
bringing vital stem cells, nutrients, amino acids, protein
signals and other resources. This would culminate in
new endothelial tissue invasion into the confines of the
substratum, supplying nutrients necessary for subse-
quent new bone tissue formation [20, 43, 44]. However,
what happens to an ex vivo tissue culture model when
such prerequisites are not present. Can a tissue at all
survive an extended culture period let alone support
new tissue morphogenesis?
Previous research has shown that for complex tissues
to properly survive in vitro they require certain condi-
tions and special applications to survive, such as elec-
trical or biomechanical stimulation [24]. Survival is
limited, in which long term studies ultimately leads to
tissue degeneration in which diffusion of nutrients and
tissue building resources cannot reach the relevant cells
as the vascular capillary system collapses [45]. This
limits the tissue development in vitro to a critical size
that permits nutrient diffusion, in particular the thicker
a tissue ultimately becomes in vitro will generate survival
issues. Indeed, in the present study, COL4A1 was origin-
ally chosen as it is a well-known biomarker for angio-
genesis, where it is critical in the basement membrane
formation of new capillaries and partially also in endo-
thelial tissue development [14, 15, 17]. VEGF-A was
included after interest was aroused at whether angiogen-
esis could also be developed, as it is known to support
the endothelial tissue formation and act as a paracrine
signaling molecule on the development and proliferation
of endothelial cells [46]. Interestingly, qRT-PCR analysis
and histological observations in our proof-of-concept
study revealed that COL4A1 and VEGF-A was only
briefly up-regulated within the wrapping model at day
15, after which the tissue died off in tissue culture. On
the other hand, the β-TCP/HA device pouched in ab-
dominal skeletal muscle sites, harvested and then cul-
tured in vitro, showed a consistent and almost
regulatory pattern of endothelium proliferation and/or
angiogenesis up to 30 days at either transcriptional or
translational level. This could also, at least for connect-
ive and endothelial-like tissue formation and invasion
into the β-TCP/HA bioceramics, were validated histo-
logically (Fig. 6). Here new connective tissue formation
was histologically apparent by day 30, invading the
Fig. 4 Microbiological culture results of the 30-day culturing
medium with a pouch model. No microbial contamination is
detected in the 30-day culturing medium with a pouch model
(right plate)
Fig. 5 Chronological osteogenic-related gene expression pattern in both wrapping and pouch model (a-c). Pouch models showed superior
osteogenic differentiation capacity at day 15 (b) and 30 (c) comparing wrapping models. Error bars are Mean ± SEM. Ns, non-statistically
significant; **, P < 0.01; ***, P < 0.001
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macroporous superstructure of the devices, near the per-
ipheries only. This deviation between the wrapping and
pouch models clearly reflects the criteria of diffusion of
nutrients across certain tissue thickness in vitro. On one
hand, the wrapping model with a muscle thickness of al-
most 1500 μm prevented proper nutrient flow to the in-
trinsic muscle cells near the biomaterial-cell interphase.
This on the other hand was not the case for the pouch
model in which the muscle tissue thickness from
medium-cell and cell-biomaterial interphase was only
500 μm thick. Moreover, whilst true osteogenesis eluded
our investigations, as this was not a central aim as yet at
this point, the gene expression level of RUNX-2 in-
creased considerably at both day 15 and 30 in the pouch
groups with also positive up-regulation of BMP-2 and
TGF-β1. This suggests that the presently utilized orga-
noid pouch model has the potential to induce new bone
formation at an in vitro cell culturing level, as it was
demonstrated to do in vivo in various animal models
[16, 23, 27, 47, 48]. Again, possibly because of the stem
cell availability and absent tissue morphogenesis due to
a lack of an active blood supply that would normally
bring in extra progenitor stem cells and even monocyte/
macrophages critical for osteoclastogenesis [16] bone
formation was retarded. Multiple studies reported that
interconnection pathways have a strong impact on new
tissue development, with incomplete and undersized
pore interconnection limiting efficient connective tissue
infiltration and blood vessels invasion into the scaffold
[34]. However, in the present study, the average diam-
eter of the interconnection pathway was ~ 40 μm, indi-
cating the limited capacity for sound tissue and vascular
invasion. This could explain why connective tissue for-
mation and vascular survival were only observed in this
study at the peripheral macropores with diameter larger
than 500 μm. This leaves new strategic avenues open to
improve the responsive signals in the system. Follow-up
experiments need to be considered to investigate this as-
pect further and see how other substrata would affect
tissue morphogenesis in vitro.
However, aside from the initial validations of the
in vitro organoid pouch model as a tissue model to be
utilized for further investigations with good survival
chances as well as partial osteogenic support combined
with angiogenic responses, our study serendipitously re-
vealed new connective tissue formation and endothelial
tissue survival at the peripheral region of the heterotopic
pouch implanted β-TCP/HA devices. This suggests that
in vitro blood vessel had survived the long-term culture
period with resident cells producing the necessary sig-
nals that are required for tissue survival with the poten-
tial to angiogenesis that could support connective tissue
ingrowth into the scaffold and the subsequent osteo-
genic differentiation of mesenchymal stem cells located
within the connective tissue (Figs. 6 and 7). We postu-
late that the surrounding tissue in heterotopic sites are
Fig. 6 Maintenance of vascular structure and potential of angiogenesis in tissue pouch models up to 30 days (a-d). Connective tissue grows into
the macropore of the scaffold at the periphery (a, dotted lines show the contour of the macropores), with neurovascular bundle still surviving by
30 days (b). Both transcriptional (c) and translational (d) results suggest the maintenance of angiogenesis capacity with a pouch model by 30
days, whereas the capacity is lost with a wrapping model (P < 0.01 and 0.05, respectively). Error bars are Mean ± SEM. *, P < 0.05; **, P < 0.01. H&E
staining. M = Skeletal muscle, S = scaffold, CT = connective tissue, MP =macropores, mp =micropores, BV = blood vessel, N = nerve, C = capillary.
Bar: A, 200 μm; B, 50 μm
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actively engaged in the formation of specific connective
and/or endothelial tissue formation rather than simply
providing a signal that facilitates an immunological re-
sponse or acting as a stem cell reservoir to sustain the
metabolic formation of new bone by induction with an
insoluble substratum [13, 16–18, 47].
Various investigations into in vitro metabolistic effects
of cells removed from their natural environment and
cultured within an ex vivo system clearly re-iterate that
cells lose their homeostatic state where critical essential
amino acid building blocks, normally available for pro-
tein synthesis, suddenly disappear. This greatly limits ef-
ficient protein translation [26], including losing critical
energy production requirements to fuel necessary ana-
bolic activities to support formation of complex ECM
components [49]. Catabolic reactions using glucose, adi-
pose tissue or proteins are a necessary requirement for
the survival of any cell, let alone a tissue. In vitro
systems cannot adequately replicate these reactions and
might prevent cellular in vitro tissue experiments from
progressing past the generally accepted 30-day culturing
period limit [45, 50, 51]. After this, because of extensive
proliferation of cells or tissues, the catabolic breakdown
into basic components and energy might be insufficient
to meet the anabolic synthetic requirements to maintain
cells and/or tissues active in vitro and might therefore
limit their capacity to form larger complex organs. How-
ever, in light of the histological results of the present
study of the skeletal muscle pouched β-TCP/HA bio-
ceramic devices cultured in vitro at days 15 and 30, we
hypothesize that the muscle tissue rescues the catabolic
and anabolic homeostasis by behaving as a catabolic res-
ervoir that breaks down into base components. Previous
research by Brand (1997), Albert (2005) including Nel-
son and Cox (2005), have shown that as tissue degener-
ates in vitro it has the potential to release glucose,
Fig. 7 Representative morphology and tissue response to devices in pouch models at day 30 (a-i). Extensive connective tissue forms (a and b)
around the scaffold, with comprehensive mucin deposition (e in blue) and fibrils (e in red) evenly distributed in between, consistent with the
gene expression pattern showing proliferation and angiogenesis (i). A tissue layer forms at the interface contacting medium (b and f), where
fibrous-like cells line at the surface of tissue (b), producing condensed fibers (f in red) underneath. Cells releasing from muscle fiber (c) migrate
within the mucin-fibril rich extracellular matrix (g) towards either outer layer or scaffold (d and h). The osteoid (h, area in scarlet) mesh at the
interface (dashed lines) between tissue and scaffold indicates the osteogenic transformation of the connective tissue, which is supported by BMP-
2 gene expression results (P < 0.05). Error bars are Mean ± SEM. *,#, P < 0.05; **, P < 0.01. H&E staining (a-d); Movat pentachrome staining (e-h).
M = Skeletal muscle, S = scaffold. Bar: A and E, 200 μm; B-D, F-H 50 μm
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proteins but also critically essential amino acid that
could be utilized as energy and building blocks by resi-
dent cells to support new tissue development, as seen at
the peripheries of the bioceramic to muscle tissue inter-
phase (Fig. 7) of the present study. This would allow
resident stem cells to undergo differentiation and prolif-
eration into the macroporous spaces of the bioceramic
device, depositing new endothelial tissue matrix that
could support vascular structures. There the culturing
medium might act as a nutrient source to more effect-
ively transport biochemical buildings blocks and nutri-
ents into the confines of the device, providing the means
for tissue survival. This form of cell differentiation and
tissue repurposing or “hypertrophic tissue transform-
ation” needs to be further validated and elucidated if it
indeed is some type of tissue “recycling” modus or is
simply an artefact of deterioration. Similarly, the benefit
of a tissue organoid in vitro culturing system over stand-
ard cell culture modes still needs to be assessed further.
We believe that the tissue organoid model might more
efficiently support critical catabolic and anabolic mecha-
nisms and assist in more complex cytological reactions,
to help form more complex organ structures.
Conclusions
The present proof-of-concept study clearly showed that
an organoid pouch model exhibits superior survivability
and more consistent tissue growth in vitro compared
with a wrapping model, thereby rendering the approach
promising for follow-up bone inductive endeavors pro-
vided the correct material and/or signals are present to
facilitate this reaction. However, whilst the in vitro tissue
inductive model can support the development in part of
an angiogenic response, the culturing system needs to be
further supplemented and enhanced with either the rele-
vant stem cells including monocytes/macrophages/oste-
oclasts uniting a synthetic circulatory system that would
enable future in vitro models to function as an in vivo
system would. Subsequently, differences in molecular
signals between in vitro and in vivo pouch models, in-
cluding macro and micro signals involved in new au-
togenous bone formation, still need to be determined
that would enable such future models to fully replicate
the in vivo environment ex vivo.
Methods
Aims and study design
The present pilot study explored the tissue behavior and
cell survival capability within a new in vitro skeletal
muscle tissue-based biomaterial organoid bioreactor.
Eighteen 3D printed β-tricalcium phosphate/hydroxy-
apatite devices were either wrapped in a sheet of rat rec-
tus abdominis muscle tissue (n = 9) or first implanted in
a heterotopic rectus abdominis muscle pouch (n = 9) that
was then excised and cultured in vitro for up to 30 days.
Normal rectus abdominis muscle tissue without im-
plants, uncultured, served as the endogenous control to
which all samples were compared to. Specimens were
harvested at 5 days, 15 days and 30 days (n = 3 per time
point), respectively and underwent qRT-PCR and histo-
logical analyses. Supernatants of tissue cultures were
assayed for angiogenic/vasculogenic protein production,
fresh medium was the control.
3D printed β-tricalcium phosphate/hydroxyapatite
devices (β-TCP/HA) devices
Eighteen devices were provided by BioMed Center
Innovation gGmbH (Bayreuth, Germany). According to
the BioMed Center, the 3D-printed β-TCP/HA biocera-
mic devices (Fig. 1a) had been manufactured using a
mixture of tri-calcium phosphate and hydroxyapatite
powders (Merck, Kenilworth, NJ, USA)) at a ratio of
40%:60%, respectively. The mixture had previously been
spray-nozzle granulated from a water-based slurry with
addition of organic dispersing and binding agents using
a custom spray-dryer (Trema, Kemnath) and cut off at
100 μm using a classing sieve (Retsch, Haan, Germany).
The lower fraction of the granulate was coated with or-
ganic adhesion-improving agents by means of fluidized
bed coating; the final printing powder had size distribu-
tion values of d10 = 34.87 μm, d50 = 61.86 μm and d90 =
93.33 μm. After mixing the powder with a combination
of organic additives (trade secret), the scaffolds were
then printed out in a Z310 3D-Printer (3D Systems,
Rock Hill, USA) using the standard colorless ink pro-
vided with the printer. After de-powdering, the scaffolds
were sintered at 1250 °C, producing a solid, organic-free,
porous bioceramic device with macroscopic pore chan-
nels (670.52 +/− 97.60 μm) resulting from printing de-
sign and smaller internal pores (80.95 +/− 23.38 μm) as
described above. The devices were then allowed to cool,
after which they were cleaned using deionized water,
packed and sterilized by vacuum pulse autoclaving.
Skeletal muscle-based biomaterial culturing models
Commercially available, four adult male Rattus norvegi-
cus Fischer 344/DuCrl rats (Charles River Laboratories,
Sulzbach, Germany), were utilized in the pilot study, and
equally split between the two tissue models. Animals
were euthanized with an overdose of isoflurane (Abbot,
Chicago, USA). This was done in accordance to the rules
and regulations of the Animal Protection Laboratory
Animal Regulations (2013), European Directive 2010/63/
EU and approved by the Animal ethics research commit-
tee (AESC) of the Ludwig Maximillian’s University of
Munich (LMU), Bavaria, Germany Tierschutzgesetz §1/
§4/§17 (https://www.gesetze-im-internet.de/tierschg/
TierSchG.pdf) with respect to animal usage for pure
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tissue or organ harvest only. No muscle tissue was pur-
chased commercially or otherwise. All muscle tissue uti-
lized in the study was extracted by our laboratories from
commercially bought adult male Rattus norvegicus
Fischer 344/DuCrl rats (Charles River Laboratories).
Two skeletal muscle tissue biomaterial-based models
were designed and tested:
Tissue wrapping model
For the tissue wrapping model, n = 9 β-TCP/HA devices,
were first immersed in normal growth medium com-
posed of Dulbecco’s modified Eagle medium–high glu-
cose (DMEM-hg) (Biochrom GmbH, Berlin, Germany),
40 IU/mL penicillin (Biochrom GmbH) and 40 IU/mL
streptomycin (Biochrom GmbH).
Two F-344 adult male rats (Charles River Laboratories)
were euthanized under sterile conditions, the rectus abdom-
inis skeletal muscle tissue harvested, placed in normal
DMEM-hg after which 3D printed β-TCP/HA devices were
wrapped in the sheets of rectus abdominis muscle tissue
(Fig. 1b-f). Nine β-TCP/HA devices were then wrapped
with a skeletal rectus abdominis muscle sheet, and divided
into 3 culturing periods set at 5, 15 and 30 days. Each cul-
turing period contained 3 tissue bags. Rectus abdominis
muscle tissue without β-TCP/HA devices was cultured in
parallel to tissue bags and acted as controls. Medium was
changed every 2 days. Fresh rectus abdominis muscle tissue
was used in the normalization of qRT-PCR.
Tissue pouch model
Nine β-TCP/HA devices were prepared by placing them
in normal growth medium as explained in the section of
the tissue wrapping model. Rats were then euthanized
under sterile conditions, β-TCP/HA devices were imme-
diately implanted in intramuscular rectus abdominis
muscle pouches created by sharp and blunt dissection
(Fig. 1g-j). Once all β-TCP/HA devices had been im-
planted, rectus abdominis muscle tissue pouches with
biomaterials were excised using 8 mm biopsy punches
(PFM medical, Cologne, Germany). Nine rectus abdom-
inis muscle pouches with β-TCP/HA were created, and
divided into 3 culturing periods set at 5, 15 and 30 days.
Each culturing period contained 3 tissue pouches. Rectus
abdominis muscle tissue without β-TCP/HA devices
were cultured in parallel to tissue pouches and acted as
controls. Medium was changed every 2 days. Fresh rectus
abdominis muscle tissue was used in the normalization
of qRT-PCR.
After the allotted culturing period, specimens with β-
TCP/HA devices were harvested and cut midways, with
one-half flash frozen in liquid nitrogen for qRT-PCR as-
says and the other half fixed in 4% paraformaldehyde
(Microcos GmbH, Garching, Germany) to be processed
for histological and histomorphometric analysis.
Bacterial contamination assay
The 30-day organoid pouch model devices, during histo-
logical analysis, were observed containing a filamentous
fibrous-like material. To exclude the likelihood that the fi-
brous like material was not of bacterial origin and in fact
fibrin fibrils, the medium collect for quantitative protein
analysis from these samples was subjected to a bacterial
contamination test. Under sterile conditions collected cul-
ture medium was plated out on a standard Luria Broth
Agar (LA) plates (1 g Tryptone, 1.5 g Technical agar, 0.5 g
Yeast extract, 0.5 g NaCl (all (Sigma-Aldrich)) in 100ml
dH2O), with a normal LA plate with fresh DMEM-hg
(Biochrom GmbH) medium set as control. After 72 h of
incubation at 37 °C with 5% CO2, plates were assessed for
bacterial colony formation by one blinded analyst (Yan
Chevalier).
QRT-PCR
QRT-PCR was performed to determine the relative gene
expression quantity of tissue growth related genes espe-
cially angiogenesis and endothelial tissue formation
genes, VEGF-A, COL4A1 and TGF-β1 including known
osteogenesis signaling and structural markers, specific-
ally RUNX-2 and BMP-2.
Specimen fragments for qRT-PCR were ground to
powder in the presence of liquid Nitrogen. Total RNA
was then isolated using a modified RNA Trizol extrac-
tion procedure (Chomczynski & Mackey, 1995). Briefly,
1 ml Trizol (Invitrogen, San Diego, CA, USA) was added
to the powderised tissue, where through the addition of
chloroform (Sigma-Aldrich) the aqueous RNA contain-
ing phase was transferred to Isopropanol (Sigma-Al-
drich). RNA was then pelleted out in an overnight
centrifugation step at 4 °C, which were then washed with
75% ethanol dried and resuspended in 32 μl RNase free
water. The concentration of the RNA was determined
using a NanoDropTMLite (Thermo Scientific, Waltham,
USA) and quality assessed with a Bioanalyzer 2100
(Agilent Technologies, CA, USA). RNA integrity num-
bers lower than 8 were not accepted. RNA was then re-
verse transcribed into complementary DNA (cDNA)
using the QuantiTect Reverse Transcription cDNA Syn-
thesis Kit (Qiagen, Hilden, Germany).
QRT-PCR was then performed, in duplicate with FastStart
Essential DNA Green Master (Roche, Basel, Switzerland) in
a final reaction volume of 10 μl, using a LightCycler® 96 ther-
mocycler (Roche). Each reaction contained 10 ng cDNA; 2x
FastStart Essential DNA Green Master and 10 μM of each
primer (Table 1). Primers were designed using Integrated
DNA Technologies PrimerQuest Tool (https://eu.idtdna.
com/Primerquest/Home/Index). Use of GeNorm (http://
medgen.ugent.be/~jvdesomp/genorm/) established that ribo-
somal protein large P0 (RPLP0), succinate dehydrogenase
complex subunit A (SDHA), RNA polymerase II subunit E
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(POLR2E) and TATA binding protein (TBP) were the most
appropriate internal reference genes to use in this experi-
ment. All amplified PCR products underwent Sanger se-
quencing (GATC Biotech, Cologne, Germany) and were
then analyzed utilizing nucleotide analysis (https://blast.ncbi.
nlm.nih.gov/Blast.cgi? PAGE_TYPE=BlastSearch) to con-
firm that the correct sequence had been amplified. QRT-
PCR thermocycling parameters included a pre-incubation of
3min at 95 °C, followed by a three-step amplification pro-
gram of 40 cycles consisting of a denaturation, annealing and
extension step set at 95 °C for 10 s, 60 °C for 15 s and 72 °C
for 30s, respectively. Relative gene expression was normalized
against four reference genes. Gene expression from the har-
vested tissue/device models was normalized to the four refer-
ence genes and fresh abdominal skeletal muscle tissue using
the Qbase+ software (http://www.biogazelle.com). Gene ex-
pression results were represented as mean calibrated normal-
ized relative quantities (CNRQs) ± standard error, which
reflect the log10 2
-ΔΔCt.
Histological evaluation
Specimens were fixed in 4% paraformaldehyde
(Microcos GmbH) for 24 h after which they were
processed for paraffin wax embedding. Prior to cut-
ting 10 μm sections the surface of each paraffin block
was decalcified [52]. In order to validate our gene ex-
pression patterns with respect to tissue survivability
within the two tissue models, histological sections
were stained using either the hematoxylin (Morphisto
GmbH, Frankfurt, Germany) and eosin (H&E) staining
[53] (Morphisto GmbH) or the Movat pentachrome
staining [54] (Morphisto GmbH). Stained sections
were subsequently analyzed under PreciPoint M8
microscope (PreciPoint, Freising, Germany).
Quantitative angio−/vasculogenic protein assays
The amount of VEGF-A produced by the two bioreac-
tors and controls were determined using Magnetic
Luminex® Assays (R&D systems, Minneapolis, USA). Su-
pernatants of tissue cultures were harvested at 5 days,
15 days and 30 days for either the wrapping model speci-
mens or the pouch model specimens and controls. Ab-
solute VEGF-A content in supernatants were measured
according to the manufacturer’s instructions. Results
were generated using xPONENT® 4.2 for MAGPIX® Soft-
ware (R&D systems, Minneapolis, USA).
Statistical analysis
Data were analyzed using GraphPad Prism v8.0.1
(GraphPad Software, San Diego, USA). The results were
represented as mean ± standard error (SEM). Measure-
ments were performed in triplicate or duplicate when no
valid data could be obtained from one sample per group.
The Mann-Whitney test was used to detect statistical
differences with α = 0.05. Statistical significance was in-
dicated by ns for no significance, * for p < 0.05, ** for
p < 0.01 and *** for p < 0.001.
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